TC
Alaunos Therapeutics, Inc.
TCRT · NASDAQ
$1.51 -1.95% (-$0.03)
1M -21.76%
Market Cap $3.81M
P/E Ratio -
Div. Yield -
ROE 232.60%
Piotroski F-Score Weak
1/9Valuation
14 /100
Expensive P/B 5.84x
P/S 1,269.59x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 61.78%
Rev. growth 88.04%
FCF growth N/A
Profitability
0 /100
Weak Net margin 133,667.00%
Op. margin 135,267.00%
FCF margin 94,166.60%
Quality
0 /100
Poor ROE 232.60%
ROA 264.51%
Asset turnover 0.00x
Debt
74 /100
Low Current ratio 0.77x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
29 /100
Unstable Rev. volatility 104.01%
EPS volatility 38.77%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TCRT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Holger Weis
Employees
1
Headquarters
Fort Lauderdale
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report